Cargando…

Ribavirin for Chronic Hepatitis E Virus Infection in Ibrutinib-Exposed Patients

Ibrutinib is an oral first-in-class Bruton’s tyrosine kinase inhibitor approved for the therapy of various B-cell lymphoid malignancies. Among ibrutinib-related infections, viral hepatitis are poorly described. We report our single-center experience with 4 cases of chronic hepatitis E virus infectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Protin, Caroline, Abravanel, Florence, Alric, Laurent, Tavitian, Suzanne, Obéric, Lucie, Izopet, Jacques, Martin-Blondel, Guillaume, Ysebaert, Loic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798245/ https://www.ncbi.nlm.nih.gov/pubmed/31660412 http://dx.doi.org/10.1093/ofid/ofz345

Ejemplares similares

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies
por: Tavitian, Suzanne, et al.
Publicado: (2015)

Venetoclax with high‐dose methotrexate and rituximab seem effective and well‐tolerated in the treatment of central nervous system involvement of chronic lymphocytic leukemia: A case report
por: Beziat, Guillaume, et al.
Publicado: (2020)

Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis
por: Kamar, Nassim, et al.
Publicado: (2016)

Rat Hepatitis E Virus: Presence in Humans in South-Western France?
por: Parraud, Delphine, et al.
Publicado: (2021)

Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin
por: Lhomme, Sebastien, et al.
Publicado: (2019)

Limited Sampling Strategy for Determination of Ibrutinib Plasma Exposure: Joint Analyses with Metabolite Data
por: Le Louedec, Félicien, et al.
Publicado: (2021)

Insertions and Duplications in the Polyproline Region of the Hepatitis E Virus
por: Lhomme, Sébastien, et al.
Publicado: (2020)

Hepatitis E Virus Infection: Neurological Manifestations and Pathophysiology
por: Lhomme, Sébastien, et al.
Publicado: (2021)

Hepatitis E Virus Infection in Solid Organ Transplant Recipients, France
por: Lhomme, Sebastien, et al.
Publicado: (2017)

Clinical Manifestations, Pathogenesis and Treatment of Hepatitis E Virus Infections
por: Lhomme, Sébastien, et al.
Publicado: (2020)

Performance of a commercial assay for detecting and quantifying HEV RNA in faeces
por: Abravanel, Florence, et al.
Publicado: (2018)

Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey
por: Compaci, Gisèle, et al.
Publicado: (2019)

Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies
por: Bertoli, Sarah, et al.
Publicado: (2016)

Hepatitis E Pathogenesis
por: Lhomme, Sébastien, et al.
Publicado: (2016)

Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients
por: Kamar, Nassim, et al.
Publicado: (2022)

Hepatitis E Virus: How It Escapes Host Innate Immunity
por: Lhomme, Sébastien, et al.
Publicado: (2020)

Hepatitis E prevalence in French Polynesian blood donors
por: Dimeglio, Chloé, et al.
Publicado: (2018)

Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functions
por: Series, Jennifer, et al.
Publicado: (2019)

Chronic hepatitis E virus infection in a cirrhotic patient: A case report
por: Barragué, Hugo, et al.
Publicado: (2017)

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy
por: Pradat, Pierre, et al.
Publicado: (2015)

Hepatitis E Virus Infections in Blood Donors, France
por: Gallian, Pierre, et al.
Publicado: (2014)

Rabbit Hepatitis E Virus Infections in Humans, France
por: Abravanel, Florence, et al.
Publicado: (2017)

Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse
por: Cadot, Sarah, et al.
Publicado: (2020)

Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates
por: Mehawej, Mireille, et al.
Publicado: (2015)

Hepatitis E Virus Genotype 3 Diversity, France
por: Legrand-Abravanel, Florence, et al.
Publicado: (2009)

Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3
por: Micas, Florence, et al.
Publicado: (2021)

Optimized Hepatitis E Virus (HEV) Culture and Its Application to Measurements of HEV Infectivity
por: Capelli, Nicolas, et al.
Publicado: (2020)

Hepatitis E Virus Quasispecies in Cerebrospinal Fluid with Neurological Manifestations
por: Abravanel, Florence, et al.
Publicado: (2021)

Electrocardiographic Changes Associated With Ibrutinib Exposure
por: Fradley, Michael G., et al.
Publicado: (2020)

Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients
por: Del Bello, Arnaud, et al.
Publicado: (2022)

Clustered Cases of Waterborne Hepatitis E Virus Infection, France
por: Lhomme, Sébastien, et al.
Publicado: (2023)

Hepatitis E Virus Strains in Rabbits and Evidence of a Closely Related Strain in Humans, France
por: Izopet, Jacques, et al.
Publicado: (2012)

Effector memory CD8 T cell response elicits Hepatitis E Virus genotype 3 pathogenesis in the elderly
por: El Costa, Hicham, et al.
Publicado: (2021)

Glucocorticoids selectively affect the memory T cell response to SARS-Cov2 spike in vaccinated and post-infected patients with systemic lupus erythematosus
por: Renaudineau, Yves, et al.
Publicado: (2023)

Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein
por: Abravanel, Florence, et al.
Publicado: (2020)

Diagnostic Performance of an Automated System for Assaying Anti-Hepatitis E Virus Immunoglobulins M and G Compared with a Conventional Microplate Assay
por: Abravanel, Florence, et al.
Publicado: (2022)

Determining the therapeutic range for ribavirin in transplant recipients with chronic hepatitis E virus infection
por: Mulder, Midas B., et al.
Publicado: (2020)

Sustained Virologic Response for Chronic Hepatitis C Infection After 27 Days of Treatment with Sofosbuvir and Ribavirin
por: Meissner, Eric G., et al.
Publicado: (2014)

Hepatitis E Virus Infection without Reactivation in Solid-Organ Transplant Recipients, France
por: Legrand-Abravanel, Florence, et al.
Publicado: (2011)

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
por: Kamar, Nassim, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dt91t2ognr09guh2ikm6p1c4r2